Investor082,
The May timeline is yours from last year not mine; ). You said the clock would start soon, I only agreed that the Wednesdays on the last half of any month are the days most likely for an MHRA announcement. I said $90,000,000 based on 600 patients is possible. I never said when approval would happen. I have said I believe Flaskworks is likely linked to the timing of approval as well as NWBO’s willingness to accept the expected NICE reimbursement rate. The further out before approval, the closer to Flaskworks readiness for trials and for commercial manufacturing has come now that the 2023 prototype has been decided upon. Set aside funding will also cover demand better as well before running into the need for NICE reimbursement to take over. Looking forward to the scale up while 600 plus patients get treated through self pay and set aside finding to create that $90,000,000 in revenue. I like FeMike’s “missed it by that much” for your almost one year miss so far with the approval date I shared on this thread; ). Best wishes.
Market Data 
Markets 
